|
?:authorAffiliation
|
-
[\'Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.\', \'Center for Virology, Medical University of Vienna, Vienna, Austria.\', \'Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.\', \'Laboratory for Immunopathology, Department of Clinical Immunology and Allergology, Sechenov First Moscow State Medical University, Moscow, Russia.\', \'Department of Materials and Environmental Chemistry, University of Stockholm, Stockholm, Sweden.\', \'Viravaxx AG, Vienna, Austria.\', \'Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.\', \'Karl Landsteiner University of Health Sciences, Krems, Austria.\', \'Labors.at, Vienna, Austria.\', \'Österreichische Gesundheitskasse, Klinikum Peterhof, Baden, Austria.\', \'Institute of Molecular Biosciences, BioTechMed Graz, University of Graz, Graz, Austria.\', \'NRC Institute of Immunology, FMBA, Moscow, Russia.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}